ACADIA Pharmaceuticals Inc.ACADNASDAQ
Loading
Year-over-year earnings per share growth rate
5Y CAGR
+65.6%/yr
Long-term compound
Percentile
P97
Near historical high
vs 5Y Ago
12.5x
Strong expansion
Streak
3 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 276.74% |
| Q3 2025 | 168.75% |
| Q2 2025 | 45.45% |
| Q1 2025 | -87.36% |
| Q4 2024 | 335.00% |
| Q3 2024 | 0.00% |
| Q2 2024 | 100.00% |
| Q1 2024 | -64.29% |
| Q4 2023 | 170.00% |
| Q3 2023 | -5982.35% |
| Q2 2023 | 102.52% |
| Q1 2023 | -3.85% |
| Q4 2022 | -52.94% |
| Q3 2022 | 19.05% |
| Q2 2022 | 70.00% |
| Q1 2022 | -159.26% |
| Q4 2021 | -200.00% |
| Q3 2021 | 66.67% |
| Q2 2021 | 35.71% |
| Q1 2021 | 0.00% |
| Q4 2020 | 22.22% |
| Q3 2020 | -100.00% |
| Q2 2020 | 52.63% |
| Q1 2020 | -67.65% |
| Q4 2019 | -17.24% |
| Q3 2019 | 23.68% |
| Q2 2019 | 35.59% |
| Q1 2019 | -18.00% |
| Q4 2018 | 0.00% |
| Q3 2018 | 1.96% |
| Q2 2018 | -15.91% |
| Q1 2018 | 20.00% |
| Q4 2017 | -3.77% |
| Q3 2017 | 3.64% |
| Q2 2017 | 23.61% |
| Q1 2017 | -10.77% |
| Q4 2016 | -6.56% |
| Q3 2016 | 3.17% |
| Q2 2016 | -40.00% |
| Q1 2016 | 0.00% |